Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin detemir plus metformin with versus without dietary intervention in type 2 diabetes
2009-014894-42Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of insulin detemir and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Novo Nordisk. Primary endpoint: Weight change from baseline to end of treatment. Started Jun 2010; status: completed.
02
Drugs
insulin detemirmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-014894-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014894-42.